6.61Open8.60Pre Close5 Volume4 Open Interest90.00Strike Price3.29KTurnover264.04%IV0.90%PremiumOct 4, 2024Expiry Date5.69Intrinsic Value100Multiplier0DDays to Expiry0.76Extrinsic Value100Contract SizeAmericanOptions Type-0.9624Delta0.0266Gamma15.40Leverage Ratio-1.6855Theta-0.0001Rho-14.82Eff Leverage0.0010Vega
Dollar General Stock Discussion
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
No comment yet